Add to ORKGclinical performance of the cardiac troponin I (cTnI) assay from Beckman-Coulter Diagnostics. This assay had a unique combination of monoclonal antibodies with 2 monoclonal antibodies directed against epitopes near the NH2 terminus of the heart-specific region of troponin I. The approach has been adopted by the new cTnI assay from Abbott Diagnostics. The aim of our study was to investigate whether this approach affects the clinical performance of cTnI assays. Methods: Cardiac troponin concentrations were mea-sured in a random sample of patients with unstable coronary artery disease included in the GUSTO IV trial (n 696) by the AccuTnI (Beckman-Coulter Diagnos-tics), Architect cTnI (Abbott Diagnostics), Immulite 2500 cTnI (Diagnostics Produ...
BACKGROUND The aim of this study was to validate the clinical performance of the Beckman Access h...
Background: Until now, high-sensitivity cardiac troponin (hs-cTn) assays were mainly developed for l...
Background: As a part of an International Federation of Clinical Chemistry and Laboratory Medicine (...
Background: Recent guidelines for use of cardiac troponin to detect cardiac damage and for cardiovas...
BACKGROUND: The aim of this study was to validate the clinical performance of the Beckman Access hig...
Background: Available assays for cardiac troponin I (cTnI) yield numerically different results. The ...
BACKGROUND We aimed to validate the clinical performance of the high-sensitivity cardiac troponin...
BACKGROUND: The aim of this study was to compare the clinical performance of 2 sensitive cTnI assays...
Background: Recent guidelines for use of cardiac tropo-nin to detect cardiac damage and for cardiova...
BACKGROUND: We aimed to validate the dinical performance of the high-sensitivity cardiac troponin I ...
BACKGROUND: Reliability of cardiac troponin-I assays under real-time conditions has not been previou...
Background: High-sensitivity cardiac troponin I (hs-cTnI) assays have been developed that quantify l...
Background: High-sensitivity cardiac troponin I (hs-cTnI) assays have been developed that quantify l...
OBJECTIVES: The aim of this study is to determine the imprecision profile, 99th percentile and diag...
BACKGROUND: Efficient rule-out of acute myocardial infarction (MI) facilitates early disposition of ...
BACKGROUND The aim of this study was to validate the clinical performance of the Beckman Access h...
Background: Until now, high-sensitivity cardiac troponin (hs-cTn) assays were mainly developed for l...
Background: As a part of an International Federation of Clinical Chemistry and Laboratory Medicine (...
Background: Recent guidelines for use of cardiac troponin to detect cardiac damage and for cardiovas...
BACKGROUND: The aim of this study was to validate the clinical performance of the Beckman Access hig...
Background: Available assays for cardiac troponin I (cTnI) yield numerically different results. The ...
BACKGROUND We aimed to validate the clinical performance of the high-sensitivity cardiac troponin...
BACKGROUND: The aim of this study was to compare the clinical performance of 2 sensitive cTnI assays...
Background: Recent guidelines for use of cardiac tropo-nin to detect cardiac damage and for cardiova...
BACKGROUND: We aimed to validate the dinical performance of the high-sensitivity cardiac troponin I ...
BACKGROUND: Reliability of cardiac troponin-I assays under real-time conditions has not been previou...
Background: High-sensitivity cardiac troponin I (hs-cTnI) assays have been developed that quantify l...
Background: High-sensitivity cardiac troponin I (hs-cTnI) assays have been developed that quantify l...
OBJECTIVES: The aim of this study is to determine the imprecision profile, 99th percentile and diag...
BACKGROUND: Efficient rule-out of acute myocardial infarction (MI) facilitates early disposition of ...
BACKGROUND The aim of this study was to validate the clinical performance of the Beckman Access h...
Background: Until now, high-sensitivity cardiac troponin (hs-cTn) assays were mainly developed for l...
Background: As a part of an International Federation of Clinical Chemistry and Laboratory Medicine (...